
Sign up to save your podcasts
Or


The combination of mifepristone and misoprostol is currently the most common abortion method in the US, and increased access to medication abortion through telemedicine is the only way for many patients in restrictive states to access care. Now states like Texas are attacking that access, despite decades of definitive safety data for mifepristone. In this episode, Bev and Jonas talk with Dr. Daniel Grossman, Professor of Obstetrics and Gynecology at UCSF and the director of ANSIRH (Advancing New Standards in Reproductive Health). He breaks down the history, safety, and current advances in science related to medication abortion and shares the facts you need to combat misinformation, especially about mifepristone.
Are you interested in making a tax-deductible donation to support the podcast? Click here!: https://www.gifts.duke.edu/dukehealth?designation=391001053
By Beverly Gray & Jonas Swartz4.5
185185 ratings
The combination of mifepristone and misoprostol is currently the most common abortion method in the US, and increased access to medication abortion through telemedicine is the only way for many patients in restrictive states to access care. Now states like Texas are attacking that access, despite decades of definitive safety data for mifepristone. In this episode, Bev and Jonas talk with Dr. Daniel Grossman, Professor of Obstetrics and Gynecology at UCSF and the director of ANSIRH (Advancing New Standards in Reproductive Health). He breaks down the history, safety, and current advances in science related to medication abortion and shares the facts you need to combat misinformation, especially about mifepristone.
Are you interested in making a tax-deductible donation to support the podcast? Click here!: https://www.gifts.duke.edu/dukehealth?designation=391001053

26,012 Listeners

14,655 Listeners

113,121 Listeners

56,944 Listeners

21,991 Listeners

15,024 Listeners

3,354 Listeners

7,306 Listeners

16,512 Listeners

331 Listeners

16,970 Listeners

4,163 Listeners

714 Listeners

564 Listeners